Michele Gottardi

5PUBLICATIONS
39CO-AUTHORS
Gene and molecular therapyMedical molecular engineering of nucleic acids and proteinsHaematological tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 28, 2026
Outcomes of patients with de novo and secondary acute myeloid leukaemia treated with front-line hypomethylating agents and venetoclax: A retrospective Italian study.

|Feb 13, 2025
New Combination Regimens vs. Fludarabine, Cytarabine, and Idarubicin in the Treatment of Intermediate- or Low-Risk Nucleophosmin-1-Mutated Acute Myeloid Leukemia: A Retrospective Analysis from 7 Italian Centers.

Giulia Battaglia, Davide Lazzarotto, Ilaria Tanasi

|Oct 28, 2023
Hematologic Neoplasms Associated with Down Syndrome: Cellular and Molecular Heterogeneity of the Diseases.

Edoardo Peroni, Michele Gottardi, Lucia D'Antona

|Jul 14, 2023
Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in "Real-Life": The SEIFEM Experience.

Luana Fianchi, Fabio Guolo, Francesco Marchesi

|Oct 07, 2020
CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program.

Fabio Guolo, Luana Fianchi, Paola Minetto

Pageof 1

Frequent Collaborators

2 joint publications

Fabio Guolo

2 joint publications

Livio Pagano

2 joint publications

Mario Tiribelli

1 joint publications

Sara Galimberti